GSE169356 FOXA1 inhibition prostate gland Ivermectin 2 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE169356_FOXA1 inhibition_prostate gland_Ivermectin_2_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE169356_FOXA1 inhibition_prostate gland_Ivermectin_2_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE169356_FOXA1 inhibition_prostate gland_Ivermectin_2_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE169356_FOXA1 inhibition_prostate gland_Ivermectin_2_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

lactotransferrin

Gene

selenoprotein P

Gene

secretory leukocyte peptidase inhibitor

Gene

argininosuccinate synthase 1

Gene

cell division cycle 20

Gene

interferon alpha inducible protein 6

Gene

apolipoprotein D

Gene

CD9 molecule

Gene

stearoyl-CoA desaturase

Gene

insulin like growth factor binding protein 2

  • Gene

    lactotransferrin



  • Gene

    secretory leukocyte peptidase inhibitor


  • Gene

    argininosuccinate synthase 1


  • Gene

    cell division cycle 20


  • Gene

    interferon alpha inducible protein 6


  • Gene

    apolipoprotein D



  • Gene

    stearoyl-CoA desaturase


  • Gene

    insulin like growth factor binding protein 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.